Genericon Pharma Ges.m.b.H. Iasis Pharmaceuticals Hellas S.A.-Koropi Labomed Pharmaceutical Company S.A. PharmaPath S.A.

The medicine is used in adults, adolescents, and children from 2 years of age to reduce the number of seizures in the treatment of epilepsy with partial seizures (with or without secondary generalization).

Dosage form: solution, oral

ATC: N03AX23